Project Details
Description
Phase II Study of Sipuleucel-T and 1-Methyl-D-Tryptophan (1-MT) in the Treatment of Patients with Asymptomatic or Minimally Symptomatic Metastatic Hormone Refractory Prostate Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/12 → 6/30/19 |
Funding
- DENDREON CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.